We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.

Delisted

AMPE was delisted on the 12th of April, 2024.

34 hedge funds and large institutions have $98.8K invested in Ampio Pharmaceuticals Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 3534 (-1)

21% less capital invested

Capital invested by funds: $125K → $98.8K (-$25.9K)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
6
Closed
4
Calls
$69K
Puts
Net Calls
+$69K
Net Calls Change
-$2K

AMPE Hedge Fund Activity: Q2 2023 in Review

34 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2023, worth a combined $98.8K — down 21% from $125K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AMPE and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.

The largest buyer was IHT Wealth Management, opening a new position worth an estimated $5.86K. The largest seller was HRT Financial, cutting an estimated $27.7K.

  • 34 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2023, down from 35 in Q1 2023.
  • Funds reported $98.8K of Ampio Pharmaceuticals Inc. stock for Q2 2023, down 21% quarter-over-quarter.
  • 3 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2023 and 4 closed out, a net change of -1 holder.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2023 was IHT Wealth Management, an estimated $5.86K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2023 was HRT Financial, an estimated $27.7K sold.

Based on aggregated 13F filings for Q2 2023.